Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
BMC Cardiovasc Disord
Cagrilintide is a long-acting amylin agonist that has 84% homology to native human amylin with several amino acid substitutions and other chemical alterations to enhance stability, potency and biological half-life [3, 6]
Portion sizes shrink naturally
J Biol Chem 277 (51): 49446
78 HP 160 CAGRILINTIDE Long-Acting Amylin Analog ALIASES Cagrilintide, AM833, long-acting amylin analog CLASS Synthetic amylin analog once-weekly dual amylin/calcitonin agonist FORMULA CHNO (approx) SEQUENCE 37-residue amylin analog with C20-fatty-acid albumin tether HALF-LIFE ~7 days (once-weekly dosing) ROUTES Subcutaneous (Phase 2/3 clinical) MECHANISM OF ACTION Long-acting amylin analog
useful to see whether systemic inflammation is trending down
US$ 26.36
US$ 28.10
US$ 22.63
US$ 27.11
